Aufsätze
| 2011
| Neuner B, von Mackensen S, Krümpel A, Manner D, Friefeld S, Nixdorf S, Frühwald M,
deVeber G, Nowak-Göttl U.
Health-related Quality of Life in Children and Adolescents with Stroke, Self-Reports, and Parent/Proxies Reports: Cross-Sectional
Investigation.
Ann Neurol 2011;70:70-78 DOI: 10.1002/ana.22381
| 2009
| Normann S, de Veber G, Fobker M, Langer C, Kenet G, Bernard TJ, Fiedler B, Sträter R, Goldenberg NA, Nowak-Göttl U.
Role of Endogenous Testosterone Concentration in Pediatric Stroke.
Ann Neurol 2009;66:754-758
| 2007
| Kennet G, Kirkham F, Niederstadt Th, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier Ch, Heller Ch, Knöfler R, Schobess R,
Zieger B, Sébire G, Nowak-Göttl U and the European Thrombosis Study Group.
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentere cohort study.
Lancet Neurol 2007; 6: 595-603 DOI:10.1016/S1474-4422(07)70131-x
Golomb M.
The risk of recurrent venous thromboembolism after cerebral sinovenous thrombosis.
Lancet Neurol 2007; 6: 573-575
| 2004
| Kosch A, Kuwertz-Bröking E, Heller C, Kurnik K, Schobess R, Nowak-Göttl U.
Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up.
Blood 2004;104:1356-1360
Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U, Childhood Thrombophilia Study Group.
Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children.
Thromb Haemostasis 2004;91:308-314
| 2003
| Heller Ch, Heinicke A, Junker R, Knöfler R, Kosch A, Kurnik K, Schobess R, von Eckstein A, Sträter R, Zieger B,
Nowak-Göttl U.
Cerebral Venous Thrombosis in Children - a multifactorian Origin.
Circulation 2003;108:1362-1367
Kurnik K, Kosch A, Sträter R, Schobess R, Heller Ch, Nowak-Göttl U.
Recurrent Throm-boembolism in Infants and Children Suffering from Symptomatic Neonatal Arterial Stroke - A Prospective Follow-up Study.
Stroke 2003;34:2887-2893
Nowak-Göttl U, Günther G, Kurnik K, Sträter R, Kirkham F.
Arterial ischemic stroke in neonates, infants and children: an overview of underlying conditions, imaging methods and treatment modalities.
Semin Thromb Hemost 2003 Aug; 29 (4):405-414. Review
| 2002
| Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, Kurnik K, Schobess R, Nowak-Göttl U.
Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study.
Lancet 2002;360:1540-1545
| 2001
| Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R.
The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotyp is not associated with ischemic stroke in a population of German children.
Eur J Haematol 2001;66:57-62
Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U.
Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients - a prospective follow-up study.
Stroke 2001;32:2554-2558
| 2000
| Günther G, Junker R, Sträter R, Schobess R, Kurnik K, Kosch A, Nowak-Göttl U.
Symptomatic ischemic stroke in full-term neonates: Role of acquired and genetic prothrombotic risk factors.
Stroke 2000;31:2437-2441
| 1999
| Nowak-Göttl U, Sträter R, Heinicke A, Junker R, Koch HG, Schuierer G, Eckardstein A.
Lipoprotein (a) and Genetic Polymorphism of Clotting Factor V, Prothrombin and Methylenetetrahydrofolate Reductase are risk factors of spontaneous ischemic stroke in
childhood.
Blood 1999;94:3678-3682
| Sträter R, Vielhaber H, Kassenböhmer R, von Kries R, Göbel U, Nowak-Göttl U.
Genetic risk factors of thrombophilia in ischamic stroke of cardiac origin. A prospective ESPED survey.
Eur J Pediatr 1999;158 [Suppl 3]:S122-S125
| | | | | | | | | | | | | | | |